Medarex and Centocor in antibody deal

Centocor, a wholly owned subsidiary of Johnson & Johnson (JNJ), and other JNJ affiliates will receive access to MEDX's HuMab-Mouse technology for an unlimited number of targets. MEDX will receive tech...